Can a vaccine-led approach end NSW’s outbreak in 100 days, or at least substantially reduce morbidity and mortality?
Laxman Bablani, Tim Wilson, Hassan Andrabi, Vijaya Sundararajan, Driss Ait Ouakrim, Patrick Abraham, Jason Thompson, Tony Blakely
doi: https://doi.org/10.1101/2021.08.18.21262252
Laxman Bablani
1Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia
Tim Wilson
1Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia
Hassan Andrabi
1Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia
Vijaya Sundararajan
2Department of Medicine, University of Melbourne, Melbourne, Australia
3Department of Public Health, La Trobe University, Melbourne, Australia
Driss Ait Ouakrim
1Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia
Patrick Abraham
4Health Economics Unit, Centre for Health Policy; Melbourne School of Population and Global Health; University of Melbourne
Jason Thompson
5Transport, Health and Urban Design Research Lab; Melbourne School of Design; University of Melbourne
Tony Blakely
1Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted August 21, 2021.
Can a vaccine-led approach end NSW’s outbreak in 100 days, or at least substantially reduce morbidity and mortality?
Laxman Bablani, Tim Wilson, Hassan Andrabi, Vijaya Sundararajan, Driss Ait Ouakrim, Patrick Abraham, Jason Thompson, Tony Blakely
medRxiv 2021.08.18.21262252; doi: https://doi.org/10.1101/2021.08.18.21262252
Can a vaccine-led approach end NSW’s outbreak in 100 days, or at least substantially reduce morbidity and mortality?
Laxman Bablani, Tim Wilson, Hassan Andrabi, Vijaya Sundararajan, Driss Ait Ouakrim, Patrick Abraham, Jason Thompson, Tony Blakely
medRxiv 2021.08.18.21262252; doi: https://doi.org/10.1101/2021.08.18.21262252
Subject Area
Subject Areas
- Addiction Medicine (346)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2636)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12206)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4081)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2639)
- Health Policy (1002)
- Hematology (362)
- HIV/AIDS (849)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3861)
- Nursing (209)
- Nutrition (575)
- Oncology (2017)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6512)
- Radiology and Imaging (1396)
- Respiratory Medicine (871)
- Rheumatology (403)
- Sports Medicine (342)
- Surgery (442)
- Toxicology (52)
- Transplantation (185)
- Urology (165)